Jul 21, 2022 6:00pm EDT ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Jul 19, 2022 8:30am EDT ProPhase Labs to Host Live Webcast to Discuss Business Developments on Thursday, July 21, 2022
Jun 28, 2022 8:30am EDT ProPhase Labs Announces Formation of ProPhase BioPharma, Inc. (PBIO) for the Licensing and Development of Novel Drugs, Compounds and Biotechnology
May 18, 2022 8:15am EDT ProPhase Labs to Present at the H.C. Wainwright 2022 Global Investment Conference
May 11, 2022 6:25pm EDT ProPhase Labs to Present at the Spring Into Action – Best Ideas Virtual Investor Conference
